Evidence map›Paper›PMID 24666417›Full record

ArticleBritish journal of pharmacology2015

Change in functional selectivity of morphine with the development of antinociceptive tolerance.

T A Macey, E N Bobeck, K L Suchland, M M Morgan, S L Ingram

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Making Sense of Pharmacology: Inverse Agonism and Functional Selectivity.The international journal of neuropsychopharmacology · 2018
    Review
  8. Article
  9. Article
  10. Sex Differences in GABAA Signaling in the Periaqueductal Gray Induced by Persistent Inflammation.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2016
    Article
  11. Article
  12. Article
  13. Themed section.British journal of pharmacology · 2015
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

T A MaceyDepartment of Neurological Surgery, Oregon Health & Science University, Portland, OR, USA.
E N Bobeck
K L Suchland
M M Morgan
S L Ingram
Neurological Surgery · USWashington State University Vancouver · USOregon Health & Science University · US

Funding

Psychostimulants induce long-term changes in nociception.R01DA027625 · NIDA · WASHINGTON STATE UNIVERSITY · PI AICHER, SUE A, INGRAM, SUSAN L · 2009 to 2013
$2.3M
Role of the MAP Kinase Pathway ERK1/2 in Morphine ToleranceF32DA023318 · NIDA · WASHINGTON STATE UNIVERSITY · PI MACEY, TARA A · 2008 to 2009
$101k
NIDA NIH HHS DA023318NIDA NIH HHS DA027625NIDA NIH HHS F32 DA023318NIDA NIH HHS R01 DA027625
6 · The paper itself

Abstract

background and purposeOpioids, such as morphine, are the most effective treatment for pain but their efficacy is diminished with the development of tolerance following repeated administration. Recently, we found that morphine activated ERK in opioid-tolerant but not in naïve rats, suggesting that morphine activation of μ-opioid receptors is altered following repeated morphine administration. Here, we have tested the hypothesis that μ-opioid receptor activation of ERK in the ventrolateral periaqueductal gray (vlPAG) is dependent on dynamin, a protein implicated in receptor endocytosis. EXPERIMENTAL APPROACH: Rats were made tolerant to repeated microinjections of morphine into the vlPAG. The effects of dynamin on ERK activation and antinociception were assessed by microinjecting myristoylated dominant-negative dynamin peptide (Dyn-DN) or a scrambled control peptide into the vlPAG. Microinjection of a fluorescent dermorphin analogue (DERM-A594) into the vlPAG was used to monitor μ-opioid receptor internalization. KEY

resultsMorphine did not activate ERK and Dyn-DN administration had no effect on morphine-induced antinociception in saline-pretreated rats. In contrast, morphine-induced ERK activation in morphine-pretreated rats that was blocked by Dyn-DN administration. Dyn-DN also inhibited morphine antinociception. Finally, morphine reduced DERM-A594 internalization only in morphine-tolerant rats indicating that μ-opioid receptors were internalized and unavailable to bind DERM-A594. CONCLUSIONS AND IMPLICATIONS: Repeated morphine administration increased μ-opioid receptor activation of ERK signalling via a dynamin-dependent mechanism. These results demonstrate that the balance of agonist signalling to G-protein and dynamin-dependent pathways is altered, effectively changing the functional selectivity of the agonist-receptor complex. LINKED ARTICLES: This article is part of a themed section on Opioids: New Pathways to Functional Selectivity. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2015.172.issue-2.

Indexed as

Analgesics, OpioidAnimalsDrug ToleranceDynaminsExtracellular Signal-Regulated MAP KinasesHot TemperatureMaleMorphineOpioid PeptidesPainPeriaqueductal GrayRats, Sprague-DawleyReceptors, Opioid, muAnalgesics, OpioiddermorphinDynaminsExtracellular Signal-Regulated MAP KinasesMorphineOpioid PeptidesReceptors, Opioid, muendocytosisERKfunctional selectivityligand biasmorphinemorphine toleranceopiateopioidperiaqueductal gray

Identifiers

PMID24666417
PMCPMC4292967
OpenAlexW1584844864

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.